Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- PMID: 20555067
- DOI: 10.1093/annonc/mdq160
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Similar articles
-
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of locally recurrent or metastatic breast cancer (MBC).Ann Oncol. 2005;16 Suppl 1:i10-2. doi: 10.1093/annonc/mdi816. Ann Oncol. 2005. PMID: 15888735 No abstract available.
-
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol. 2011 Sep;22 Suppl 6:vi25-30. doi: 10.1093/annonc/mdr372. Ann Oncol. 2011. PMID: 21908499 No abstract available.
-
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol. 2012 Oct;23 Suppl 7:vii11-9. doi: 10.1093/annonc/mds232. Ann Oncol. 2012. PMID: 22997442 No abstract available.
-
Locally recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.Ann Oncol. 2009 May;20 Suppl 4:15-8. doi: 10.1093/annonc/mdp115. Ann Oncol. 2009. PMID: 19454439 Review. No abstract available.
-
[Treatment guideline for advanced or recurrent breast cancer].Nihon Rinsho. 2000 Apr;58 Suppl:237-45. Nihon Rinsho. 2000. PMID: 11026001 Review. Japanese. No abstract available.
Cited by
-
Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey.Curr Oncol. 2011 Aug;18(4):180-90. doi: 10.3747/co.v18i4.913. Curr Oncol. 2011. PMID: 21874117 Free PMC article.
-
Tumors that acquire resistance to low-dose metronomic cyclophosphamide retain sensitivity to maximum tolerated dose cyclophosphamide.Neoplasia. 2011 Jan;13(1):40-8. doi: 10.1593/neo.101174. Neoplasia. 2011. PMID: 21245939 Free PMC article.
-
Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer.J Cancer Res Clin Oncol. 2012 Feb;138(2):221-9. doi: 10.1007/s00432-011-1091-0. Epub 2011 Nov 18. J Cancer Res Clin Oncol. 2012. PMID: 22095437 Free PMC article. Review.
-
Overcoming resistance and restoring sensitivity to HER2-targeted therapies in breast cancer.Ann Oncol. 2012 Dec;23(12):3007-3016. doi: 10.1093/annonc/mds200. Epub 2012 Aug 2. Ann Oncol. 2012. PMID: 22865781 Free PMC article. Review.
-
Evolving approaches to metastatic breast cancer patients pre-treated with anthracycline and taxane.BioDrugs. 2013 Oct;27(5):469-78. doi: 10.1007/s40259-013-0038-1. BioDrugs. 2013. PMID: 23658121 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical